Certara Launches Version 8.3 of Phoenix™ Biosimulation Software for Drug Development

Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.—June 24, 2020. Certara®, the global leader in biosimulation, today announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. Version 8.3 delivers new features to drive efficiencies and … Continued

Accelerating Therapeutics for COVID-19

This webinar will explain lessons learned from preparing for and responding to viral outbreaks such as H5N1 and pH1N1 influenza and discuss how insights from model-informed drug development approaches can spur access to medicines for patients.

1 of 49
Back to top
Powered by Translations.com GlobalLink OneLink Software